Clinical Trial Update: A Clinical Study of Outcomes in Foot and Ankle Bone Grafting Using map3® Cellular Allogeneic Bone Graft [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating map3 Cellular Allogeneic Bone Graft for foot and ankle conditions was terminated; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Deformities
• Disorders of the Joints of the Foot
• Foot Deformities
• Foot Fracture

Drugs mentioned

• map3 Cellular Allogeneic Bone Graft

Snippet

Sponsor: RTI Surgical | Conditions: Foot Deformities, Acquired, Disorder of Joint of Foot | Phase 4 | Status: TERMINATED | Results posted: 2015-04-01